Does ELTROMBOPAG OLAMINE Cause Aplastic anaemia? 149 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Aplastic anaemia have been filed in association with ELTROMBOPAG OLAMINE (ELTROMBOPAG). This represents 0.9% of all adverse event reports for ELTROMBOPAG OLAMINE.
149
Reports of Aplastic anaemia with ELTROMBOPAG OLAMINE
0.9%
of all ELTROMBOPAG OLAMINE reports
47
Deaths
70
Hospitalizations
How Dangerous Is Aplastic anaemia From ELTROMBOPAG OLAMINE?
Of the 149 reports, 47 (31.5%) resulted in death, 70 (47.0%) required hospitalization, and 15 (10.1%) were considered life-threatening.
Is Aplastic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG OLAMINE. However, 149 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG OLAMINE Cause?
Platelet count decreased (3,419)
Death (2,797)
Drug ineffective (1,117)
Platelet count increased (980)
Fatigue (868)
Headache (750)
Nausea (584)
Diarrhoea (558)
Product use in unapproved indication (545)
Malaise (516)
What Other Drugs Cause Aplastic anaemia?
ECULIZUMAB (345)
CYCLOPHOSPHAMIDE (332)
CYCLOSPORINE (331)
METHOTREXATE (281)
BUSULFAN (220)
FLUDARABINE (220)
ETOPOSIDE (186)
VINCRISTINE (173)
CYTARABINE (163)
DOXORUBICIN (136)
Which ELTROMBOPAG OLAMINE Alternatives Have Lower Aplastic anaemia Risk?
ELTROMBOPAG OLAMINE vs ELUXADOLINE
ELTROMBOPAG OLAMINE vs ELVITEGRAVIR
ELTROMBOPAG OLAMINE vs EMAPALUMAB
ELTROMBOPAG OLAMINE vs EMAPALUMAB-LZSG
ELTROMBOPAG OLAMINE vs EMEND